New York Genome Center (VSports app下载)

📍 On the margins of #UNGA80 Beyond multilateral commitments, I had the opportunity to meet with leading experts and institutions: ➡️ Dr Bruce Wollman, MD, FACR (Kaiser Permanente): discussion on prevention, technology integration and cost management. Kaiser Permanente’s integrated system is widely recognized for efficiency and innovation. ➡️ Dr Richard Mayeux (Columbia University): exchange on the latest research progress on Alzheimer’s disease V体育官网入口. ➡️ New York Genome Center: overview of cutting-edge research activities and genomic sequencing platforms. ➡️ Dr Nadine Fornelos Martins (Harvard Medical School): discussion on Harvard’s deep expertise across all domains of medicine, science and health care, and on opportunities for cooperation. These meetings provide valuable insights and avenues for collaboration to strengthen Luxembourg’s health system. 🌍🇱🇺 Ministère de la Santé et de la Sécurité sociale Luxembourg Gouvernement luxembourgeois.

🌟Faces of IICD Spotlight: Beatrice Grauman-Boss Beatrice is a PhD student in the Vicković Lab at the New York Genome Center. Her research focuses on building a spatially resolved roadmap of cancer evolution, investigating how tumor–microenvironment interactions drive cellular plasticity, and leveraging CRISPR and spatial transcriptomics to uncover new therapeutic insights. 🎥In our latest Faces of IICD, find out what inspires Beatrice and what her interests are outside of the lab by watching her video feature here: https://bit V体育官网. ly/3K0Xidr #FacesOfIICD #CancerResearch #SpatialTranscriptomics #PhDLife #WomenInSTEM #IICD #ColumbiaUniversity Columbia University Graduate School of Arts and Sciences, Herbert Irving Comprehensive Cancer Center, Columbia University Biomedical Engineering, Columbia Engineering.

A new bioRxiv preprint from the Dan-Avi Landau lab at New York Genome Center showcases the unmatched combination of sensitivity, efficiency, and cost-effectiveness made possible by paired-plus-minus sequencing (ppmSeq):   🔹 Unprecedented sensitivity: Tumor-informed #ctDNA detection down to one-in-ten million (10⁻⁷), far beyond the limits of today’s #MRD assays 🔹 High efficiency & low sequencing requirements: Superior dsDNA recovery reduces sequencing needs 10–100×, enabling a cost-effective whole-genome approach 🔹 Low-input friendly: >20× coverage per ng of cfDNA, expanding access for challenging #liquidbiopsy applications 🔹 Broad clinical potential: Effective in both tumor-informed and tumor-naive MRD settings   #ppmSeq is poised to transform cancer monitoring and other applications demanding extreme accuracy VSports手机版. Link to preprint: https://lnkd. in/gpmAC66z Link to PR: https://lnkd. in/gRBgnaJV  #CancerGenomics #PrecisionMedicine.

Wrapping up weeks 7 & 8 with the New York Genome Center 🧬 ✅ This week I had the pleasure of presenting my final internship project to NYGC, where I developed an automated vulernability reporting system using Python that connected Rapid7 InsightVM to Eramba GRC. I created the project with the intention of further supporting our rollout of Eramba to the organization that began when I started the internship. These past two weeks have been crunch-time between supporting our day to day security operations and preparing for my presentation. It’s been incredibly rewarding to apply both technical skills and user-centered thinking to solve real problems for the organization. I’m feeling proud, grateful, and energized as I close out this experience with a team doing mission-driven work for NYGC at the intersection of science and cybersecurity. Many thanks to Patrick Damon, Ph.D. and Charles Gagnon for trusting me with your systems, and to the entire IT team that helped me so much during this process. Also a big thank you to John Coppinger and Rachelle Dond for supporting the success of the interns this cycle through recent unique funding challenges.